Acute endophthalmitis after intravitreal injection and preventive effect of preoperative topical antibiotics

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 10, 2013, Pages 900-905

  Park, Yuli ^a   Kim, Kyu Seop ^a   Park, Young Hoon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; CEFTAZIDIME; EYE DROPS; MOXIFLOXACIN; PERFLUTREN; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASEPSIS; BACTERIUM CULTURE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CENTRAL SEROUS RETINOPATHY; CLINICAL FEATURE; CLINICAL PRACTICE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG INDICATION; DRUG SELF ADMINISTRATION; ENDOPHTHALMITIS; FEMALE; HUMAN; INCIDENCE; INFECTION PREVENTION; INTRAVITREAL DRUG ADMINISTRATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTPATIENT DEPARTMENT; POLYPOIDAL CHOROIDAL VASCULOPATHY; PREOPERATIVE TREATMENT; PROLIFERATIVE RETINOPATHY; RETROSPECTIVE STUDY; STAPHYLOCOCCUS; SUBRETINAL NEOVASCULARIZATION; UVEITIS; VISION; VITRECTOMY;

ACUTE DISEASE; ADMINISTRATION, CUTANEOUS; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIBODIES, MONOCLONAL, HUMANIZED; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; FLUOROCARBONS; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TRIAMCINOLONE ACETONIDE; VITRECTOMY;

EID: 84890101480     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2013.0052     Document Type: Article

References (24)

1. Mason, J.O., III, White, M.F., Feist, R.M., et al. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina 28:564-567, 2008.
2. Scott, I.U., and Flynn Jr., H.W. Reducing the risk of endophthalmitis following intravitreal injections. Retina 27:10-12, 2007.
3. Fung, A.E., Rosenfeld, P.J., and Reichel, E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br. J. Ophthalmol. 90:1344-1349, 2006.
4. Diago, T., McCannel, C.A., Bakri, S.J., Pulido, J.S., Edwards, A.O., and Pach, J.M. Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina 29:601-605, 2009.
5. Brown, D.M., Kaiser, P.K., Michels, M., et al.; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 335:1432-1444, 2006.
6. Speaker, M.G., and Menikoff, J.A. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 98:1769-1775, 1991.
7. Bhavsar, A.R., Ip, M.S., and Glassman, A.R.; DRCR net Study Group, SCORE Study Group. The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCR net and SCORE clinical trials. Am. J. Ophthalmol. 144: 454-456, 2007.
8. Bhavsar, A.R., Googe Jr., J.M., Stockdale, C.R., et al., Diabetic Retinopathy Clinical Research Network. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the Diabetic Retinopathy Clinical Research Network Laser-Ranibizumab-Triamcinolone Clinical Trials. Arch. Ophthalmol. 127:1581-1583, 2009.
9. Bhatt, S.B., Stepien, K.M., and Joshi, K. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina 31:2032-2036, 2011.
10. Ta, C.N., Egbert, P.R., Singh, K., et al. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology 109:2036-2040, 2002.
11. Moss, J.M., Sanislo, S.R., and Ta, C.N. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 116:1498-1501, 2009.
12. Green-Simms, A.E., Ekdawi, N.S., and Bakri, S.J. Survey of intravitreal injection techniques among retinal specialists in the United States. Am. J. Ophthalmol. 151:329-332, 2011.
13. McCannel, C.A. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 321:654-661, 2011.
14. Kim, S.J., Toma, H.S., Midha, N.K., et al. Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology 117:2372-2378, 2010.
15. Costello, P., Bakri, S.J., Beer, P.M., et al. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Retina 26:191-195, 2006.
16. Kim, S.J., and Toma, H.S. Ophthalmic antibiotics and antimicrobial resistance: a randomized, controlled study of patients undergoing intravitreal injections. Ophthalmology 118:1358-1363, 2011.
17. Miller, D., Flynn, P.M., Scott, I.U., et al. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch. Ophthalmol. 124:479-483, 2006.
18. Hooper, D.C. Fluoroquinolone resistance among Grampositive cocci. Lancet. Infect. Dis. 2:530-538, 2002.
19. Mino de Kasper, H., Hoepfner, A.S., Engelbert, M., et al. Antibiotic resistance pattern and visual outcome in experimentallyinduced Staphylococcus epidermis endophthalmitis in a rabbit model. Ophthalmology. 108:470-478, 2001.
20. Yospaiboon, Y., Saree, S., and Pasadhika, S. Blood culture and conventional media for vitreous culture in infectious endophthalmitis. J. Med. Assoc. Thai. 88:639-642, 2005.
21. Recchia, F.M., Busbee, B.G., Pearlman, R.B., et al. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch. Ophthalmol. 123:341-346, 2005.
22. Jackson, T.L., Eykyn, S.J., Graham, E.M., and Stanford, M.R. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv. Ophthalmol. 48:403-423, 2003.
23. Chiquet, C., Cornut, P.L., Benito, Y., et al., French Institutional Endophthalmitis Study (FRIENDS) Group. Eubacterial PCR for bacterial detection and identification in 100 acute postcataract surgery endophthalmitis. Invest. Ophthalmol. Vis. Sci. 49:1971-1978, 2008.
24. Mezad-Koursh, D., Goldstein, M., Heilwail, G., et al. Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor. Retina 30:1051-1057, 2010.